Migration of smooth muscle cells is of critical importance to vascular
development, angiogenesis, neointima formation and the tissue remodeling
that occurs after vascular injury. Preliminary observations indicate
that NO elicits reorganization of the actin cytoskeleton and that it
increases the motility of rat aortic smooth muscle cells in primary
culture, but not subculture. These effects are associated with increased
levels of protein tyrosine phosphatase 1D (SHP2) in primary culture
but not subculture. We have found that a reduction of SHP2 protein levels
with antisense oligodeoxynucleotide (ODN) attenuates NO- induced motility
in primary cultures. Our goal is to investigate the role of SHP2 in
NO-induced cell motility in culture and in vivo. My research can be
divided into three interrelated parts which are described in detail.
A. Mechanisms
of NO-stimulated SHP2 expression: A1) Determine whether NO increases
SHP2 enzyme activity, concomitantly with increased protein levels. A2)
Determine whether NO increases SHP2 mRNA levels and if so, whether this
effect requires cGMP-dependent protein kinase (PKG) activity. If mRNA
levels are increased, determine whether increased mRNA synthesis can
explain this effect or whether increased mRNA stability may be involved.
A3) Determine whether NO increases the rate of SHP2 synthesis and/or
decreases the rate of SHP2 metabolism.
B. Consequences
of gain-of-function or loss-of-function of PKG or SHP2 in cultured cells:
B1) Determine whether enforced expression of PKG in subcultured cells
deficient in PKG restores the capacity of NO to increase SHP2 protein
levels and stimulate cell motility. B2) Determine whether enforced expression
of wild-type SHP2, but not catalytically inactive mutant SHP2, in subcultured
cells deficient in SHP2 enhances cell motility. B3) Determine whether
NO-elicited actin cytoskeletal reorganization and increased cell motility
in primary culture are blocked by agents that interfere with SHP2 function
and whether over-expression of SHP2 mimics the effects of NO.
C. Expression
of SHP2 and modulation of cell motility by SHP2 in vivo: Determine whether
vascular injury increases SHP2 protein levels and whether expression
of dominant-interfering mutant of SHP2 attenuates vascular injury- induced
cell motility and neointima formation. We anticipate that this project
will provide new information on mechanisms that are likely to explain
the motogenic capacity of NO in aortic smooth muscle cells and in vivo:
Determine whether vascular injury increases SHP2 protein levels and
whether expression of dominant-interfering mutant of PTP1D attenuates
vascular injury-induced cell motility and neointima formation. We anticipate
that this project will provide new information on mechanisms that are
likely to explain the motogenic capacity of NO in aortic smooth muscle
cells and in vivo.
Recent
Publications
Yellaturu CR, Ghosh SK, Rao RK, Jennings LK, Hassid A and Rao GN. A
potential role for nuclear factor of activated T cells in receptor tyrosine
kinase and G protein-coupled receptor agonist-induced cell proliferation.
Biochem J 368:183-190, 2002.
Bhanoori
M, Yellaturu CR, Ghosh SK, Hassid A, Jennings LK and Rao GN. Thiol alkylation
inhibits the mitogenic effects of platelet-derived growth factor and
renders it proapoptotic via activation of STATs and p53 and induction
of expression of caspase1 and p21waf1/cip1. Oncogene 22(1):117-30, 2003.
Chang Y,
Ceacareanu B, Dixit M, Sreejayan N and Hassid A. Nitric oxide-induced
motility in aortic smooth muscle cells: role of protein tyrosine phosphatase
SHP-2 and GTP-binding protein Rho. Circ Res 91:390-397, 2002.
Protein-tyrosine
phosphatase-1B (PTP1B) mediates the anti-migratory actions of Sprouty.
Yigzaw Y, Poppleton HM, Sreejayan N, Hassid A and Patel TB. J Biol Chem
278(1):284-288, 2003.
[HOME] [CENTER]
[DIRECTOR] [FACULTY]
[WORKING GROUP] [INJURY
LAB] [TAM]
[TAM INVESTIGATORS]
[TAM TRIALS] [NEWS]
[GIVING]